diphtheria-tetanus-acellular pertussis-inactivated poliovirus-haemophilus influenzae b conjugate-hepatitis b vaccine (Pediarix) Report issue

Vaccine Approved FDA
AACT MeSH

Active Ingredient History

NOW
  • Now
A pentavalent vaccine, also known as a 5-in-1 vaccine, is a combination vaccine with five individual vaccines conjugated into one.   Wikipedia

Chemistry

More Chemistry

Pharmacology

  • Mechanisms of Action:
  • Multi-specific: Missing data
  • Black Box: Missing data
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: Missing data

Alternative names

diphtheria-tetanus-acellular pertussis-inactivated poliovirus-haemophilus influenzae b conjugate-hepatitis b vaccine | diphtheria-tetanus-five component acellular pertussis-inactivated poliomyelitis -haemophilus influenzae type b conjugate vaccine | diphtheria-tetanus- pertussis, hepatitis b and hib combination vaccines | diphtheria,tetanus,pertussis+polio+hepatitis b+hib | diphtheria toxoid / filamentous haemagglutinin / hepatitis b surface antigen / pertussis toxoid / tetanus toxoid / haemophilus influenzae type b polysaccharide / polyribosylribitol phosphate conjugated to tetanus protein / type 1 (mahoney) / type 2 (mef-1) / type 3 (saukett) | diphtheria toxoid/ hepatitis b recombinant surface antigen/ bordetella pertussis (inactivated) /tetanus toxoid | diphtheria toxoid / tetanus toxoid / bordetella pertussis antigens: pertussis toxoid, filamentous haemagglutinin, pertactin, fimbriae types 2 and 3 / hepatitis b surface antigen produced in yeast cells / poliovirus (inactivated): type 1 (mahoney), type 2 (mef-1), type 3 (saukett) produced in vero cells/ haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate) conjugated to meningococcal protein. | diphtheria toxoid / tetanus toxoid / bordetella pertussis antigens (pertussis toxoid, filamentous haemagglutinin, pertactin) / hepatitis-b surface antigen / poliovirus (inactivated) (type 1 (mahoney strain), type 2 (mef-1 strain), type 3 (saukett strain)) | diphtheria toxoid / tetanus toxoid / bordetella pertussis antigens (pertussis toxoid, filamentous haemagglutinin, pertactin) / hepatitis b surface antigen / poliovirus (inactivated) (type-1 (mahoney strain), type-2 (mef-1 strain), type-3 (saukett strain)) / haemophilus influenzae type-b polysaccharide | diphtheria toxoid / tetanus toxoid / inactivated bordetella pertussis / hepatitis b surface antigen (rdna) / haemophilus influenzae type b polysaccharide | diphtheria toxoid / tetanus toxoid / pertussis toxoid / pertussis haemagglutin filamentous / pertactin / hepatitisb recombinant surface antigen | diphtheria toxoid /tetanus toxoid / two-component acellular pertussis(pertussis toxoidand filamentous haemagglutinin ) /inactivated poliomyelitis virus types 1,2 and 3 /haemophilus influenzae type-b polysaccharide (polyribosylribitol phosphate) conjugated to tetanus protein / hepatitis-b surface antigen | dpt-hepb-hib | dpt-ipv-hib | dt3ap-hbs-ipv | dtap(5)-ipv-hib vaccine | dtap-ipv-hib conjugate vaccine | dtap-ipv-hib-hbv conjugate vaccine | dtap-ipv-hib-hbv vaccine | dtpa-hbv-ipv/hib | dtpa-ipv/hib vaccine | hybrid 5 component dtap, vero ipv, hep b and prp-ompc | infanrix hexa | infanrix hexa vaccine | pediacel | pediarix | pentabio | pentacel | pentacel dtap-ipv-hib vaccine | pentavac | pentavalent dtwp-rhepb-hib vaccine | pentaxim | pr51 | purified diphtheria toxoid / purified tetanus toxoid / purified pertussis toxoid / purified pertussis filamentous haemagglutinin / hepatitis b surface antigen / inactivated type 1 poliovirus (mahoney) / inactivated type 2 poliovirus (mef 1) / inactivated type 3 poliovirus (saukett) / haemophilus influenzae type b polysaccharide | shan5 | v441

Organizations (40)

Research & Development (40)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (1)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (46)

Approved Indications (8)


 

Diphtheria-Tetanus-acellular Pertussis Vaccines (approved 2002)

Diphtheria-Tetanus-Pertussis Vaccine

Haemophilus Infections

Haemophilus influenzae

Haemophilus influenzae type b (approved 2008)

Hepatitis B Vaccines (approved 2002)

Poliovirus Vaccine, Inactivated (approved 2002)

Poliovirus Vaccines

Experimental Indications - Clinical Trial Phases 1-4 (43)


 

Bacterial Infections (Phase 3)

BCG Vaccine (Phase 4)

Chickenpox (Phase 3)

Diphtheria (Phase 4)

Diphtheria-Tetanus-acellular Pertussis Vaccines (Phase 4)

Diphtheria Toxoid (Phase 3)

Drug Therapy, Combination (Phase 4)

Fever (Phase 4)

Haemophilus Infections (Phase 4)

Haemophilus influenzae (Phase 3)

Haemophilus influenzae type b (Phase 4)

Healthy Volunteers (Phase 4)

Hematopoietic Stem Cell Transplantation (Phase 3)

Hepatitis B (Phase 4)

Immunity (Phase 4)

Immunization (Phase 3)

Infant (Phase 4)

Measles (Phase 3)

Meningitis (Phase 2)

Meningitis, Bacterial (Phase 3)

Meningitis, Meningococcal (Phase 3)

Meningococcal Infections (Phase 3)

Meningococcal Vaccines (Phase 3)

Mumps (Phase 3)

Neisseria meningitidis (Phase 3)

Neoplasms (Phase 2)

Pain (Phase 4)

Pertussis Vaccine (Phase 4)

Pneumococcal Infections (Phase 3)

Pneumococcal Vaccines (Phase 4)

Pneumonia, Staphylococcal (Phase 3)

Poliomyelitis (Phase 4)

Poliovirus Vaccines (Phase 3)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 4)

Rotavirus Infections (Phase 3)

Rotavirus Vaccines (Phase 3)

Rubella (Phase 3)

Safety (Phase 3)

Streptococcal Infections (Phase 4)

Tetanus (Phase 4)

Vaccines (Phase 4)

Virus Diseases (Phase 3)

Whooping Cough (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 116
  • # of Trial Organizations: 40

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue